US2003175310A1PendingUtilityA1
Identification of antigenic peptide sequences
Priority: Aug 14, 1996Filed: Dec 14, 2001Published: Sep 18, 2003
Est. expiryAug 14, 2016(expired)· nominal 20-yr term from priority
A61K 31/455A61K 45/06C07K 14/295
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Identification of linear amino acid antigenic sequences for the production of both polyclonal and monoclonal antibodies to defined antigenic domains is described. Also described are antigenic peptides identified by the described methods and antibodies thereto.
Claims
exact text as granted — not AI-modified1 . A substantially pure immunogenic polypeptide having a sequence consisting essentially of SEQ ID NO: 81 or a subsequence of SEQ ID NO: 81 that comprises amino acids 2 to 13 of SEQ ID NO: 101.
2 . The substantially pure immunogenic polypeptide of claim 1 , wherein said sequence consists essentially of SEQ ID NO: 81 or amino acids 2 to 13 of SEQ ID NO: 101.
3 . A substantially pure nucleic acid encoding an immunogenic polypeptide having a sequence consisting essentially of SEQ ID NO: 81 or a subsequence of SEQ ID NO: 81 that comprises amino acids 2 to 13 of SEQ ID NO: 101.
4 . The substantially pure nucleic acid of claim 6 , wherein said sequence consists essentially of SEQ ID NO: 81 or amino acids 2 to 13 of SEQ ID NO: 101.
5 . A substantially pure antibody that specifically binds to a polypeptide having a sequence consisting essentially of SEQ ID NO: 81 or a subsequence of SEQ ID NO: 81 that comprises amino acids 2 to 13 of SEQ ID NO: 101.Join the waitlist — get patent alerts
Track US2003175310A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.